Space Industry and Business News  
US says contaminated blood-thinner came from China

by Staff Writers
Washington (AFP) March 6, 2008
Batches of the recalled blood thinner heparin, which contained an unidentified contaminant and has been linked to 19 deaths, have ingredients that came from China, the US government said Thursday.

The federal Food and Drug Administration (FDA), which added that Germany has announced its own recall of heparin due to allergic reactions, has yet to prove that the contaminant was the cause of the deaths as well as other adverse health effects.

But the FDA said that all the US batches of heparin linked to health problems and deaths were made with ingredients that came from China.

"At this point, we do not know whether the introduction was accidental or whether it was deliberate," said FDA deputy commissioner Janet Woodcock.

"We don't know if any of the heparin products worldwide might contain this contaminant and that is something we are going to be looking into."

Magnetic resonance imagery (MRI) tests performed on the anti-coagulants showed that up to 20 percent of the active ingredient in the medication contained the unknown contaminant, the FDA said.

On February 11, the FDA announced a limited recall of Baxter International pharmaceuticals' multi-dose heparin and on February 28 the lab expanded the recall to include nearly all heparin being produced.

The injectable drug is made in part from pig intestines. Baxter's supplier, Scientific Protein Laboratories based in Wisconsin, sometimes buys the raw ingredients from unregulated shops in China, according to the New York Times.

However, Wayne Pines, a spokesman for Scientific Protein Laboratories said there was "no evidence of counterfeiting or tampering or anything of that nature."

"No one really knows what happened here," he said.

The FDA has so far received 785 complaints of health problems as well as 46 reports of death, but Woodcock said that the FDA determined that only 19 of the deaths were linked to the drug. Baxter maintains that four people have died as a result of the drug.

The Times said that the FDA has admitted to violating "its own policies by failing to inspect Scientific Protein's China plant before approving the drug for sale."

FDA inspectors who visited a plant in Changzou that makes the drug components for US production found "at least some heparin was made from 'material from an unacceptable workshop vendor.'"

Related Links
Hospital and Medical News at InternDaily.com



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


Closed reactor causes medicine shortage
Sydney (UPI) Feb 23, 2008
Delays in restarting a new nuclear reactor in Australia have forced the country to ration radiopharmaceuticals needed for medical tests.







  • Apple iPhone aiming to dethrone BlackBerry
  • Google stock price sinks on Internet ad-slump fears
  • HP And Qualcomm To Deliver Options For Worldwide Internet Access
  • Google's Android debuts in Barcelona

  • Sea Launch Prepares For The Launch Of DirecTV 11
  • Europe Launches Jules Verne Robot Space Freighter
  • Russia To Launch US Communications Satellite On March 15
  • ILS To Launch Two SIRIUS Radio Satellite On Proton Breeze M

  • Northrop, EADS to invest 600 mln dlrs in Alabama site
  • China air passenger traffic up 16.8 percent in 2007: state media
  • Environmentalists climb on Heathrow jet in airport protest: officials
  • NASA opens a rotary wing research project

  • Northrop Grumman Ships First Beyond-Line-of-Sight IP Network To US Air Force E-8C Fleet
  • Northrop Grumman Delivers Payload Module For Second Advanced EHF Military Communications Satellite
  • Orbital Awarded Contract For System F6 Satellite Program By DARPA
  • Lockheed Martin Completes Rigorous Test Of First Advanced Military Communications Satellite

  • Quasicrystal Mystery Unraveled With Computer Simulation
  • Europe's GEANT computer network extends its reach
  • Siberian Shepherd Seeks A Million Rubles Over Rocket Fragment Fall
  • Boeing Satellites Reach 2500 Years Of Accumulated On Orbit Services

  • NASA Names John Shannon New Space Shuttle Manager
  • Michael Larkin Appointed Executive Vice President Of Orbital's Satellite Business Unit
  • Boeing Integrated Defense Systems Looks To Future With Leadership Changes
  • Raytheon Space and Airborne Systems Names Carey VP For ISR Systems

  • Falcon Investigates Pollution From The Dakar Metropolis Into Desert Dust Layers
  • NASA Extends Mission For Ball Aerospace-Built ICESat
  • CIRA Scientist Among Authors Of Book Celebrating 50 Years Of Earth Observations From Space
  • Indonesia To Develop New EO Satellite

  • Mapcom Systems And Centina Systems Announce Strategic Alliance
  • Enhanced nuvi 2x5 Series Brings More Features And Options To Affordable Navigation
  • Multimedia And Entertainment Content For Portable GPS Navigation Devices In Development
  • News Service Utilises On Call Communications' QuickSPOT Automated SNG System

  • The content herein, unless otherwise known to be public domain, are Copyright Space.TV Corporation. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space.TV Corp on any Web page published or hosted by Space.TV Corp. Privacy Statement